Table 2 1-way ANOVA showing IGF-1, IGFBP-3 and their ratio differences’ between and within the CVMI stages
From: Serum IGF-1, IGFBP-3 and their ratio: Potential biochemical growth maturity indicators
Sum of squares | df | Mean square | F | Sig. | ||
|---|---|---|---|---|---|---|
Serum IGF-1 (ng/ml) | Between Groups | 566437.3 | 5 | 113287.4 | 757.07 | 0.000(**) |
Within Groups | 12569.5 | 84 | 149.6 | |||
Total | 579006.9 | 89 | ||||
Serum IGFBP-3 (ng/ml) | Between Groups | 5.29 | 5 | 1.05 | 7.42 | 0.000(**) |
Within Groups | 1.19 | 84 | 1425822.1 | |||
Total | 1.72 | 89 | ||||
IGF-1/IGFBP-3 Ratio | Between Groups | 0.006 | 5 | 0.001 | 2.77 | 0.023(*) |
Within Groups | 0.037 | 84 | 0.000 | |||
Total | 0.043 | 89 | ||||